Dina Radenkovic

Dr. Dina Radenkovic, M.B.B.S, is Co-founder and CEO of Gameto, a biotechnology company developing treatment solutions to improve women's reproductive health. Dr. Radenkovic has led Gameto from its inception, convening an experienced scientific management team to tackle groundbreaking innovations in the reproductive health field. Under her leadership, Gameto has raised $73 million from top investors including Two Sigma Ventures, RA Capital, Insight Partners, Lux Capital, Bob Nelsen of Arch Ventures, and Anne Wojcicki of 23andMe. With this support, Dr. Radenkovic and the Gameto team developed its lead program, Fertilo, with the goal of making IVF and egg freezing shorter, safer, and more accessible through reduced hormonal injections by maturing eggs outside of the body.